iBio, Inc. Appoints Vidadi Yusibov, Ph.D. Chief Scientific Officer

NEWARK, Del.--(BUSINESS WIRE)--iBio, Inc. (OTCBB:IBPM) announced today the appointment of Vidadi Yusibov, Ph.D. as Chief Scientific Officer. Dr. Yusibov is the Executive Director of the Fraunhofer USA Center for Molecular Biotechnology (CMB) in Newark, Delaware, a position he will continue to hold.

Back to news